Jump to navigation
The new program offers group and individual support sessions for students, facilitated by students. The free sessions are conducted virtually via video conferencing.
The pandemic is exacerbating many risk factors associated with drug use and overdose, including economic distress, social isolation and anxiety, says pharmacologist Todd Vanderah.
A $2.8 million grant may help develop an improved therapeutic treatment for acute ischemic stroke patients to let them recover faster with fewer long-term complications.
Three experts in law and public health write in a new essay that one of America's founding documents provides a framework for finding common ground to fight COVID-19.
New findings by UArizona chemists Wolfgang Peti and Rebecca Page provide a foundation to better understand and treat two neurological disorders.
Under a Department of Defense contract, College of Medicine – Phoenix researchers are leading an effort to develop a portable device to easily detect biological threats.
Professor Jim Schwiegerling designed an implantable lens that allows recipients to see mid-range distances in addition to near and far distances.
A $6.1 million study led by the UArizona Center for Innovation in Brain Science will test novel small molecules to improve the lives of Alzheimer's patients.
A College of Medicine – Phoenix pediatrician discusses the impact of COVID-19 on children and warns that drowning risks may increase with more kids at home this summer.
Researchers found that a program focused on yogic breathing improved participants' ability to cope with stress better than a workshop that focused on cognitive approaches to stress.
